ZINC Drug Patent Profile
✉ Email this page to a colleague
When do Zinc patents expire, and when can generic versions of Zinc launch?
Zinc is a drug marketed by Pharmafair, Exela Pharma, Hospira, Abraxis Pharm, Am Regent, Apotex, Fresenius Kabi Usa, Gland Pharma Ltd, Nivagen Pharms Inc, Somerset Theraps Llc, and Zydus Pharms. and is included in eleven NDAs.
The generic ingredient in ZINC is zinc sulfate. There are thirty-eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the zinc sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zinc
A generic version of ZINC was approved as zinc sulfate by AM REGENT on July 18th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZINC?
- What are the global sales for ZINC?
- What is Average Wholesale Price for ZINC?
Summary for ZINC
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 11 |
Drug Prices: | Drug price information for ZINC |
Drug Sales Revenues: | Drug sales revenues for ZINC |
What excipients (inactive ingredients) are in ZINC? | ZINC excipients list |
DailyMed Link: | ZINC at DailyMed |